Banister et al. (2014) study
A 2014 epidemiological study that suggested type 2 diabetics taking Metformin lived slightly longer than non-diabetics without diabetes, raising interest in Metformin as a geroprotective compound; later found to have methodological flaws.
Save the 2 videos on Banister et al. (2014) study to your own pod.
Sign up free to keep building your knowledge base on Banister et al. (2014) study as more episodes are added.
Videos Mentioning Banister et al. (2014) study
Journal Club with Dr. Peter Attia | Metformin for Longevity & The Power of Belief Effects
Andrew Huberman
An influential 2014 paper that suggested a survival advantage in type 2 diabetics treated with Metformin, which generated significant excitement for its geroprotective potential. Later re-evaluated due to methodological limitations.
300-Special episode: Peter on exercise, fasting, nutrition, stem cells, geroprotective drugs, & more
Peter Attia MD
A 2014 epidemiological study that suggested type 2 diabetics taking Metformin lived slightly longer than non-diabetics without diabetes, raising interest in Metformin as a geroprotective compound; later found to have methodological flaws.